Answer
After receiving Spravato (esketamine hydrochloride), patients must avoid driving or operating machinery until the next day following a restful sleep.
Sources for this answer
- Spravato 28 mg nasal spray, solutionJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.7 Effects on ability to drive and use machines · Version 12Document updated
Sources checked